Amy Heimberger, MD - The University of Texas M. D. Anderson Cancer Center - Professor of Neurosurery

Amy Heimberger

MD

The University of Texas M. D. Anderson Cancer Center

Professor of Neurosurery

Houston, TX | United States

Main Specialties: Neurology

Additional Specialties: Neuro-Oncology

Amy Heimberger, MD - The University of Texas M. D. Anderson Cancer Center - Professor of Neurosurery

Amy Heimberger

MD

Introduction

Primary Affiliation: The University of Texas M. D. Anderson Cancer Center - Houston, TX , United States

Specialties:

Additional Specialties:

Research Interests:

Publications

100Publications

4511Reads

-Profile Views

3551PubMed Central Citations

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.

Neuro Oncol 2017 Aug;19(8):1047-1057

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas; Caris Life Sciences, Phoenix, Arizona; Departments of Biostatistics, Neuro-Pathology, Neuro-Oncology, Pediatrics, and Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570198PMC
August 2017
40 Reads
19 Citations
5.562 Impact Factor

Tumor Vaccines for Malignant Gliomas.

Neurotherapeutics 2017 04;14(2):345-357

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-017-0522-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398993PMC
April 2017
42 Reads
6 Citations

Immune Checkpoint Inhibitors in Gliomas.

Curr Oncol Rep 2017 Apr;19(4):23

NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW, 1450, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0586-5DOI Listing
April 2017
28 Reads
5 Citations
2.891 Impact Factor

Serum microRNA profiling in patients with glioblastoma: a survival analysis.

Mol Cancer 2017 03 11;16(1):59. Epub 2017 Mar 11.

Department of Neuro-Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-017-0628-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346242PMC
March 2017
24 Reads
2 Citations
4.260 Impact Factor

Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?

Immunotherapy 2016 ;8(4):413-23

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Department of Neurosurgery, 1400 Holcombe Blvd, Unit 442, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.16.2DOI Listing
December 2016
52 Reads
2.440 Impact Factor

Principles of immunotherapy.

Handb Clin Neurol 2016 ;134:163-81

Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-802997-8.00010-4DOI Listing
December 2016
41 Reads
2 Citations

Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells.

Oncotarget 2016 Nov;7(44):72021-72032

Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342141PMC
November 2016
27 Reads
2 Citations
6.360 Impact Factor

Interrogating Metabolism in Brain Cancer.

Magn Reson Imaging Clin N Am 2016 Nov;24(4):687-703

Department of Cancer Systems Imaging, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA; The University of Texas Health Science Center at Houston, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mric.2016.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091807PMC
November 2016
49 Reads
1 Citation
0.800 Impact Factor

Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.

Neuro Oncol 2016 10 1;18(10):1357-66. Epub 2016 Jul 1.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (S.T.G., Y.H., A.B.H.); Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (S.-P.W., J.d.G.); Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (R.G.W.V.); Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (S.Z.); Department of Neuropathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (G.N.F.); Caris Life Sciences, Phoenix, Arizona, USA (J.X., Z.G., S.K.R., D.S.); The University of Sydney, Sydney, Australia (M.K.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035527PMC
October 2016
46 Reads
14 Citations
5.562 Impact Factor

GBM-associated mutations and altered protein expression are more common in young patients.

Oncotarget 2016 Oct;7(43):69466-69478

Departments of Neurosurgery, Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.11617DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342491PMC
October 2016
33 Reads
6.360 Impact Factor

The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.

Int Rev Immunol 2016 07 26;35(4):325-339. Epub 2014 Sep 26.

a Department of Pediatrics-Research , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08830185.2014.956360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257246PMC
July 2016
25 Reads
8 Citations
4.103 Impact Factor

miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.

Cancer Res 2016 07 31;76(14):4293-304. Epub 2016 May 31.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-3073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033679PMC
July 2016
40 Reads
6 Citations
9.330 Impact Factor

Immunotherapy in glioblastoma: emerging options in precision medicine.

CNS Oncol 2016 07 26;5(3):175-86. Epub 2016 May 26.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns-2016-0009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926530PMC
July 2016
31 Reads
2 Citations

Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor.

J Immunother 2016 06;39(5):205-17

*Division of Pediatrics Departments of ‡Biostatistics ∥Neurosurgery §Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center †The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847343PMC
June 2016
61 Reads
2 Citations
4.010 Impact Factor

MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.

Neuro Oncol 2016 05 11;18(5):639-48. Epub 2015 Dec 11.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas (J.W., E.K.N., L.-Y.K., Y.H., S.X., K.G., X.L., N.H., A.B.H.); Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas (W.Q., S.Z.); Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas (C.I.); Departments of Neuropathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (G.N.F.); Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.R.G.); Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (W.O.); Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas (G.A.C.); Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, China (S.X.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov292DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827047PMC
May 2016
38 Reads
22 Citations
5.562 Impact Factor

Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression.

Oncoimmunology 2016 May 21;5(5):e1117739. Epub 2015 Dec 21.

Departments of Neurosurgery, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1117739DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910740PMC
May 2016
38 Reads
3 Citations
6.283 Impact Factor

Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes.

Oncotarget 2016 Apr;7(15):20486-95

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7974DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991469PMC
April 2016
51 Reads
4 Citations
6.360 Impact Factor

PD-L1 expression and prognostic impact in glioblastoma.

Neuro Oncol 2016 Feb 30;18(2):195-205. Epub 2015 Aug 30.

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (E.K.N., J.W., N.K.Y., N.H., L.-Y.K., K.G., X.L., A.B.H.); Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (S.Z.); Center for RNA Interference and Non-Coding RNAs, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.I.); Flow Cytometry and Cell Imaging Core Facility, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (J.K.B.); Neuropathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (G.N.F.); Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (G.A.C.); Neuro-Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.A.C.); Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.C., K.R.); Lion Biotechnologies, Woodland Hills, California (J.Q.C., L.R.); Dept. of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida (J.Q.C., L.R.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/early/2015/
Web Search
http://neuro-oncology.oxfordjournals.org/lookup/doi/10.1093/
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724183PMC
February 2016
89 Reads
59 Citations
5.562 Impact Factor

MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer.

J Gene Ther 2016 Feb 13;2(1). Epub 2016 Feb 13.

Department of Thoracic & Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927004PMC
http://dx.doi.org/10.13188/2381-3326.1000006DOI Listing
February 2016
48 Reads
7 Citations

Immunosuppressive mechanisms in glioblastoma.

Neuro Oncol 2015 Nov;17 Suppl 7:vii9-vii14

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (E.K.N., A.B.H.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625890PMC
November 2015
50 Reads
26 Citations
5.562 Impact Factor

Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity.

Cancer Res 2015 Sep;75(17):3505-18

Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-0139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624228PMC
September 2015
103 Reads
60 Citations
9.330 Impact Factor

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

J Natl Cancer Inst 2015 Aug 13;107(8). Epub 2015 May 13.

Department of Pediatric Research (JY, JH, DD, XX, SL) and Department of Neurosurgery (LYK, KG, ABH), The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554195PMC
August 2015
33 Reads
17 Citations
12.583 Impact Factor

The role of STAT3 in tumor-mediated immune suppression.

J Neurooncol 2015 Jul 22;123(3):385-94. Epub 2015 Feb 22.

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, 1400 Holcombe Blvd., Unit 442, Houston, TX, 77030, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1731-3DOI Listing
July 2015
36 Reads
8 Citations
3.070 Impact Factor

FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.

Cancer Res 2015 Jun 1;75(11):2337-48. Epub 2015 Apr 1.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-2800DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452436PMC
June 2015
37 Reads
23 Citations
9.330 Impact Factor

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Neuro Oncol 2015 Jun 13;17(6):854-61. Epub 2015 Jan 13.

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (J.S.); The Neurological Institute of Columbia University, New York, New York (R.K.L.); Stanford Cancer Center, Stanford, California (L.D.R.); Duke University Medical Center, Durham, North Carolina (D.A.R., G.E.A., D.D.B., J.H.S.); Evanston Northwestern Healthcare, Evanston, Illinois (N.A.P.); University of Texas M.D. Anderson Cancer Center, Houston, Texas (M.D.G.); University of Washington School of Medicine, Seattle, Washington (M.M.M.); Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah (R.J.); Yale University School of Medicine, New Haven, Connecticut (J.M.B); University Hospital-Case Medical Center & Case Comprehensive Cancer Center, Cleveland, Ohio (A.S.); Scott Cruickshank & Associates, Inc., Santa Barbara, C alifornia (S.C.); Celldex Therapeutics, Inc., Hampton, New Jersey (J.A.G., T.K., T.A.D.); University of Texas M.D. Anderson Cancer Center, Houston, Texas (A.B.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483122PMC
June 2015
86 Reads
75 Citations
5.562 Impact Factor

Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.

Int J Cancer 2015 May 23;136(9):2047-54. Epub 2014 Oct 23.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331224PMC
May 2015
134 Reads
3 Citations
5.085 Impact Factor

Therapeutic targets in subependymoma.

J Neuroimmunol 2014 Dec 31;277(1-2):168-75. Epub 2014 Oct 31.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2014.10.008DOI Listing
December 2014
43 Reads
4 Citations
2.470 Impact Factor

Immunotherapy for primary brain tumors: no longer a matter of privilege.

Clin Cancer Res 2014 Nov;20(22):5620-9

Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0832DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235630PMC
November 2014
29 Reads
23 Citations
8.722 Impact Factor

Epidermal growth factor receptor and variant III targeted immunotherapy.

Neuro Oncol 2014 Oct;16 Suppl 8:viii20-5

The Preston Robert Tisch Brain Tumor Center (K.L.C., P.C.G., C.M.S., J.H.S.); Division of Neurosurgery, Department of Surgery, Duke University Medical Center Durham, North Carolina (K.L.C., P.C.G., C.M.S., J.H.S.); Department of Biomedical Engineering, Duke University Durham, North Carolina (P.C.G.); Department of Pathology, Duke University Medical Center Durham, North Carolina (J.H.S.); Department of Immunology, The University of Texas M.D. Anderson Cancer Center Houston, Texas (H.G.C., L.J.N.C.); Division of Pediatrics, The University of Texas M.D. Anderson Cancer Center Houston, Texas (H.G.C., L.J.N.C.); Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center Houston, Texas (A.B.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207138PMC
October 2014
44 Reads
7 Citations
5.562 Impact Factor

Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy.

Cancer Immunol Res 2014 Sep 17;2(9):867-77. Epub 2014 Jun 17.

Department of Microbiology and Immunology, Dodson Interdisciplinary Immunotherapy Institute, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502823PMC
September 2014
39 Reads
22 Citations

Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.

J Natl Cancer Inst 2014 Aug 28;106(8). Epub 2014 Jun 28.

Affiliations of authors: Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, China (SX, X-GL), Department of Neurosurgery (SX, JW, FW, L-YK, X-YL, EN, KG, TD, YY, FFL, GR, ABH), Department of Biostatistics (WQ), Department of Pathology (GNF), and Department of Experimental Therapeutics (GAC), University of Texas M. D. Anderson Cancer Center, Houston, TX; Baylor College of Medicine, Houston, TX (NKY); Texas A&M University College of Veterinary Medicine & Biomedical Sciences, College Station, TX (VF).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271080PMC
August 2014
35 Reads
27 Citations
12.583 Impact Factor

The controversial role of microglia in malignant gliomas.

Clin Dev Immunol 2013 24;2013:285246. Epub 2013 Jul 24.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/285246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741958PMC
February 2014
25 Reads
34 Citations
2.934 Impact Factor

MicroRNAs as novel immunotherapeutics.

Oncoimmunology 2013 Aug 28;2(8):e25124. Epub 2013 May 28.

Department of Neurosurgery; The University of Texas M.D. Anderson Cancer Center; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.25124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782519PMC
August 2013
23 Reads
1 Citation
6.283 Impact Factor

Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.

Cancer Immunol Res 2013 Aug;1(2):112-22

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-13-0028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881271PMC
August 2013
50 Reads
43 Citations

miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.

Cancer Res 2013 Jul 1;73(13):3913-26. Epub 2013 May 1.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-4318DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780786PMC
July 2013
69 Reads
55 Citations
9.330 Impact Factor

BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.

Cancer Immunol Immunother 2013 Jun 17;62(6):983-7. Epub 2013 Apr 17.

Duke Brain Tumor Immunotherapy Program, Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-013-1405-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665719PMC
June 2013
47 Reads
7 Citations
3.941 Impact Factor

A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors.

J Neurosurg 2013 Apr 8;118(4):873-883. Epub 2013 Feb 8.

The Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2012.12.JNS111970DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083773PMC
April 2013
27 Reads
7 Citations
3.740 Impact Factor

The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies.

Authors:
Amy B Heimberger

Surg Neurol Int 2011 14;2:163. Epub 2011 Nov 14.

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Unit 442, 1515 Holcombe Boulevard, Houston TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2152-7806.89886DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228387PMC
October 2012
15 Reads
2 Citations

Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.

Oncotarget 2012 Sep;3(9):1036-48

Department of Neuro-Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660053PMC
http://dx.doi.org/10.18632/oncotarget.663DOI Listing
September 2012
16 Reads
27 Citations
6.360 Impact Factor

The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.

Int J Cancer 2012 Jul 24;131(1):8-17. Epub 2011 Aug 24.

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.26307DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319790PMC
July 2012
40 Reads
7 Citations
5.085 Impact Factor

Consensus on the role of human cytomegalovirus in glioblastoma.

Neuro Oncol 2012 Mar 8;14(3):246-55. Epub 2012 Feb 8.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd., Unit 442, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280809PMC
March 2012
16 Reads
88 Citations
5.562 Impact Factor

The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival.

Oncotarget 2012 Mar;3(3):336-44

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359889PMC
http://dx.doi.org/10.18632/oncotarget.475DOI Listing
March 2012
27 Reads
6 Citations
6.360 Impact Factor

Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.

Neurosurgery 2012 Jan;70(1):234-43; discussion 243-4

Brain Tumor and Neuro-Oncology Center, Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0b013e318223f5a7DOI Listing
January 2012
29 Reads
47 Citations
3.620 Impact Factor

miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.

Clin Investig (Lond) 2011 Dec;1(12):1637-1650

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Unit 442, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/cli.11.159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314429PMC
December 2011
25 Reads
2 Citations

Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.

Clin Cancer Res 2011 Jul 13;17(14):4642-9. Epub 2011 Apr 13.

Departments of Neurosurgery and Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-0414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139801PMC
July 2011
32 Reads
50 Citations
8.722 Impact Factor

Hypoxia potentiates glioma-mediated immunosuppression.

PLoS One 2011 Jan 20;6(1):e16195. Epub 2011 Jan 20.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0016195PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024401PMC
January 2011
32 Reads
48 Citations
3.234 Impact Factor

Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?

Neuro Oncol 2011 Jan 10;13(1):3-13. Epub 2010 Dec 10.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Unit 442, FC7.3021, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noq169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018912PMC
January 2011
7 Reads
41 Citations
5.562 Impact Factor

Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.

Clin Cancer Res 2010 Dec 4;16(23):5722-33. Epub 2010 Oct 4.

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1693DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999668PMC
December 2010
55 Reads
26 Citations
8.722 Impact Factor

Glioma cancer stem cells induce immunosuppressive macrophages/microglia.

Neuro Oncol 2010 Nov 28;12(11):1113-25. Epub 2010 Jul 28.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noq082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098021PMC
November 2010
32 Reads
162 Citations
5.562 Impact Factor

Immune therapeutic targeting of glioma cancer stem cells.

Target Oncol 2010 Sep 25;5(3):217-27. Epub 2010 Aug 25.

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Unit 442, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-010-0151-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262967PMC
September 2010
44 Reads
11 Citations
3.460 Impact Factor

The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.

Clin Neurosurg 2009 ;56:98-106

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
May 2010
24 Reads
9 Citations

Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.

Clin Cancer Res 2010 May 13;16(9):2550-61. Epub 2010 Apr 13.

Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-0279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936966PMC
May 2010
41 Reads
18 Citations
8.722 Impact Factor

Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.

Mol Cancer Ther 2010 Jan 6;9(1):67-78. Epub 2010 Jan 6.

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-09-0734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939737PMC
January 2010
41 Reads
69 Citations
5.683 Impact Factor

The role of tregs in glioma-mediated immunosuppression: potential target for intervention.

Neurosurg Clin N Am 2010 Jan;21(1):125-37

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nec.2009.08.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786818PMC
January 2010
21 Reads
17 Citations
1.542 Impact Factor

Clinical applications of a peptide-based vaccine for glioblastoma.

Neurosurg Clin N Am 2010 Jan;21(1):95-109

Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Box 3050, 220 Sands Building, Research Drive, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nec.2009.09.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824535PMC
January 2010
26 Reads
10 Citations
1.542 Impact Factor

EGFRvIII-targeted vaccination therapy of malignant glioma.

Brain Pathol 2009 Oct;19(4):713-23

Duke Brain Tumor Immunotherapy Program, Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1750-3639.2009.00318.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846812PMC
October 2009
31 Reads
41 Citations
3.840 Impact Factor

The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.

Expert Opin Biol Ther 2009 Aug;9(8):1087-98

University of Texas MD Anderson Cancer Center, Department of Neurosurgery, Unit 422, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712590903124346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793529PMC
August 2009
32 Reads
36 Citations
3.743 Impact Factor

A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.

Cancer Immunol Immunother 2009 Jul 11;58(7):1023-32. Epub 2008 Nov 11.

Department of Neurosurgery, Unit 442, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0618-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674523PMC
July 2009
42 Reads
30 Citations
3.941 Impact Factor

Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.

PLoS One 2009 Jun 17;4(6):e5947. Epub 2009 Jun 17.

Laboratory of Brain Tumor Biology and Genetics, University Hospital Lausanne (CHUV) and University of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005947PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694268PMC
June 2009
53 Reads
37 Citations
3.234 Impact Factor

Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patients.

Neurosurgery 2009 May;64(5):836-45; discussion 345-6

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/01.NEU.0000342405.80881.81DOI Listing
May 2009
53 Reads
27 Citations
3.620 Impact Factor

Topotecan enhances immune clearance of gliomas.

Cancer Immunol Immunother 2009 Feb 2;58(2):259-70. Epub 2008 Jul 2.

Department of Neurosurgery, Unit 442, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0550-1DOI Listing
February 2009
41 Reads
8 Citations
3.941 Impact Factor

The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.

Clin Cancer Res 2008 Dec;14(24):8228-35

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605668PMC
December 2008
38 Reads
61 Citations
8.722 Impact Factor

Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers.

Recent Pat CNS Drug Discov 2008 Nov;3(3):179-88

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157488908786242489DOI Listing
November 2008
55 Reads
7 Citations

Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines.

J Immunol Methods 2008 Nov 4;339(1):74-81. Epub 2008 Sep 4.

Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2008.08.004DOI Listing
November 2008
33 Reads
23 Citations
2.005 Impact Factor

Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.

Semin Immunol 2008 Oct 9;20(5):267-75. Epub 2008 Jun 9.

Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.smim.2008.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633865PMC
October 2008
32 Reads
63 Citations
5.170 Impact Factor

Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.

Clin Cancer Res 2008 Aug;14(16):5166-72

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0320DOI Listing
August 2008
40 Reads
85 Citations
8.722 Impact Factor

Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.

Cancer Immunol Immunother 2008 Jan 24;57(1):123-31. Epub 2007 May 24.

Department of Neurosurgery, Unit 442, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-007-0336-xDOI Listing
January 2008
59 Reads
76 Citations
3.941 Impact Factor

Altered adenosine-to-inosine RNA editing in human cancer.

Genome Res 2007 Nov 1;17(11):1586-95. Epub 2007 Oct 1.

Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gr.6493107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2045141PMC
November 2007
37 Reads
99 Citations
14.630 Impact Factor

A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.

Cancer Res 2007 Oct;67(20):9630-6

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-1243DOI Listing
October 2007
31 Reads
84 Citations
9.330 Impact Factor

Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target.

Clin Cancer Res 2007 Jun;13(12):3559-67

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2430DOI Listing
June 2007
83 Reads
5 Citations
8.722 Impact Factor

Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

Clin Cancer Res 2006 Jul;12(13):3935-41

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2202DOI Listing
July 2006
73 Reads
59 Citations
8.722 Impact Factor

The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.

Neuro Oncol 2006 Jul 14;8(3):261-79. Epub 2006 Jun 14.

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1215/15228517-2006-008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871955PMC
July 2006
50 Reads
139 Citations
5.562 Impact Factor

Innate immune functions of microglia isolated from human glioma patients.

J Transl Med 2006 Mar 30;4:15. Epub 2006 Mar 30.

Department of Neurosurgery-Unit 442, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-4-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1501057PMC
March 2006
30 Reads
27 Citations
3.930 Impact Factor

The natural history of EGFR and EGFRvIII in glioblastoma patients.

J Transl Med 2005 Oct 19;3:38. Epub 2005 Oct 19.

Department of Neurosurgery, The Brain Tumor Center, The University of Texas M, D, Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-3-38DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298339PMC
October 2005
33 Reads
58 Citations
3.930 Impact Factor

Immunotherapy for human glioma: innovative approaches and recent results.

Expert Rev Anticancer Ther 2005 Oct;5(5):777-90

University of Texas MD Anderson Cancer Center, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.5.5.777DOI Listing
October 2005
7 Reads
12 Citations
2.250 Impact Factor

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

Clin Cancer Res 2005 Feb;11(4):1462-6

Department of Neurosurgery, University of Texas M.D. Anderson Cancer Center, Unit 442, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-1737DOI Listing
February 2005
38 Reads
153 Citations
8.722 Impact Factor

Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.

Clin Cancer Res 2005 Jan;11(1):267-72

Department of Neurosurgery, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
January 2005
12 Reads
17 Citations
8.722 Impact Factor

Mechanisms of action of rapamycin in gliomas.

Neuro Oncol 2005 Jan;7(1):1-11

Brain Tumor Center, Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1215/S1152851704000420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871627PMC
January 2005
64 Reads
7 Citations
5.562 Impact Factor

Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.

J Invest Dermatol 2004 Feb;122(2):400-5

Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.0022-202X.2004.22231.xDOI Listing
February 2004
138 Reads
10 Citations
7.220 Impact Factor

A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.

Clin Cancer Res 2003 Dec;9(17):6560-6

Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77054, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/9/17/6560.full
Web Search
December 2003
55 Reads
13 Citations
8.722 Impact Factor

Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors.

Clin Cancer Res 2003 Sep;9(11):4247-54

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Unit 442, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
September 2003
12 Reads
72 Citations
8.722 Impact Factor

Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa).

Clin Cancer Res 2002 Nov;8(11):3496-502

Department of Surgery, Neurosurgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
November 2002
13 Reads
34 Citations
8.722 Impact Factor

Dendritic cells pulsed with a tumor-specific peptide induce long-lasting immunity and are effective against murine intracerebral melanoma.

Neurosurgery 2002 Jan;50(1):158-64; discussion 164-6

Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00006123-200201000-00024DOI Listing
January 2002
18 Reads
28 Citations
3.620 Impact Factor

Top co-authors

Jun Wei
Jun Wei

National Cancer Institute

31
Ling-Yuan Kong
Ling-Yuan Kong

The University of Texas M. D. Anderson Cancer Center

27
Gregory N Fuller
Gregory N Fuller

The University of Texas M. D. Anderson Cancer Center

22
John H Sampson
John H Sampson

Duke University Medical Center

22
Raymond Sawaya
Raymond Sawaya

The University of Texas M. D. Anderson Cancer Center

17
Ganesh Rao
Ganesh Rao

The University of Texas MD Anderson Cancer Center

16
Wei Qiao
Wei Qiao

China University of Petroleum

16
Waldemar Priebe
Waldemar Priebe

The University of Texas M. D. Anderson Cancer Center

14
Gary E Archer
Gary E Archer

Duke University Medical Center

13
Darell D Bigner
Darell D Bigner

Duke University Medical Center

12